↓ Skip to main content

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Overview of attention for article published in Psychopharmacology, May 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 4,326)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
64 news outlets
blogs
3 blogs
twitter
111 tweeters
facebook
2 Facebook pages
video
1 video uploader

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
39 Mendeley
Title
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Published in
Psychopharmacology, May 2019
DOI 10.1007/s00213-019-05249-5
Pubmed ID
Authors

Michael C. Mithoefer, Allison A. Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin

Twitter Demographics

The data shown below were collected from the profiles of 111 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 9 23%
Student > Bachelor 7 18%
Student > Master 7 18%
Researcher 6 15%
Student > Doctoral Student 3 8%
Other 7 18%
Readers by discipline Count As %
Unspecified 10 26%
Psychology 9 23%
Medicine and Dentistry 6 15%
Neuroscience 4 10%
Nursing and Health Professions 2 5%
Other 8 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 610. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2019.
All research outputs
#11,297
of 13,640,145 outputs
Outputs from Psychopharmacology
#3
of 4,326 outputs
Outputs of similar age
#455
of 253,694 outputs
Outputs of similar age from Psychopharmacology
#1
of 45 outputs
Altmetric has tracked 13,640,145 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,326 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.